CLINICAL_TRIALS
trial_result
· 2021-07-22
Clinical Trial Update: Psilocybin in Depression Resistant to Standard Treatments [Phase 2]
Summary
Phase 2 clinical trial update evaluating psilocybin for treatment-resistant depression.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: King's College London | Conditions: Treatment Resistant Depression | Phase 2 | Status: UNKNOWN